# Dallas IVF – FDA Inspection, Mar 28, 2024

Source: https://www.keypedia.com/records/fda_inspections/dallas-ivf/78545a43-2699-4137-9417-f4ac1d0a67ed
Source feed: FDA_Inspections

> FDA inspection 1234907 of Dallas IVF, March 28, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1234907
- Company Name: Dallas IVF
- Inspection Date: 2024-03-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1112244 - 2019-12-09](https://www.keypedia.com/records/fda_inspections/dallas-ivf/eeb2b06c-8461-463b-989b-0940d7e41c27)
- FDA Inspection 1020991 - 2017-07-11
- FDA Inspection 817417 - 2013-02-07
- FDA Inspection 667829 - 2010-06-17

## Related Officers

- [Company Rep](https://www.keypedia.com/people/richard-t-riggie/d07a4551-08b4-44f7-b7d2-02ae3c5dc1e2)

Company: https://www.keypedia.com/companies/dallas-ivf/636e12c2-9a7b-4073-ad78-59b91ace0017

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
